Literature DB >> 21883347

Functional and structural evaluation of hearing in acromegaly.

Kadriye Aydin1, Burak Ozturk, Meral Didem Turkyilmaz, Selcuk Dagdelen, Burce Ozgen, Faruk Unal, Tomris Erbas.   

Abstract

CONTEXT: The impact of acromegaly on the auditory system remains unknown.
OBJECTIVE: This study aimed to examine audiological symptoms and the structure and function of the auditory system in patients with acromegaly. DESIGN/SETTING AND PATIENTS:  The study included 44 patients with acromegaly. Pure tone audiometry, speech audiometry, tympanometry, otoacoustic emissions testing, computerized tomography of the temporal bone and magnetic resonance imaging of the ear were performed in all patients. The study also included 36 age- and sex-matched healthy controls. The patients with acromegaly were divided into three subgroups, as follows: controlled disease (n=13); partially controlled disease (n=16); uncontrolled disease (n = 15).
RESULTS: In all, 43% of the patients with acromegaly had hearing loss, and 20% had had an episode of otitis in at least one ear. Median pure tone average (PTA) in the patients with acromegaly was 12.5 dB (range: 2-72 dB), vs 8.3 dB (range: 0-20 dB) in the control group (P < 0.001). PTA did not differ significantly between the three patient subgroups. Audiometric tests showed various degrees of hearing loss in at least one ear in 21 patients (48%). Conductive, sensorineural and mixed type hearing loss in at least one ear was noted in 9%, 30% and 18% of the patients, respectively. Auditory imaging showed that 50% of the patients had temporomandibular joint degeneration (TMJD).
CONCLUSIONS: Hearing loss is quite common in patients with acromegaly. Contrary to common belief, in this study, conductive hearing loss did not occur more frequently than other types. Based on PTA findings in the controls and patients with acromegaly, acromegaly caused hearing loss, but the level of disease activity had no effect on hearing. Middle ear pressure problems might be caused by increased perilymph because of growth hormone (GH)-related volume overload.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 21883347     DOI: 10.1111/j.1365-2265.2011.04209.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Auditory changes in acromegaly.

Authors:  S Tabur; H Korkmaz; E Baysal; E Hatipoglu; I Aytac; E Akarsu
Journal:  J Endocrinol Invest       Date:  2016-12-29       Impact factor: 4.256

Review 2.  Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.

Authors:  Alin Abreu; Alejandro Pinzón Tovar; Rafael Castellanos; Alex Valenzuela; Claudia Milena Gómez Giraldo; Alejandro Castellanos Pinedo; Doly Pantoja Guerrero; Carlos Alfonso Builes Barrera; Humberto Ignacio Franco; Antônio Ribeiro-Oliveira; Lucio Vilar; Raquel S Jallad; Felipe Gaia Duarte; Mônica Gadelha; Cesar Luiz Boguszewski; Julio Abucham; Luciana A Naves; Nina Rosa C Musolino; Maria Estela Justamante de Faria; Ciliana Rossato; Marcello D Bronstein
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

Review 3.  Endocrine Glands and Hearing: Auditory Manifestations of Various Endocrine and Metabolic Conditions.

Authors:  Kripa Elizabeth Cherian; Nitin Kapoor; Suma Susan Mathews; Thomas Vizhalil Paul
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

Review 4.  Hearing Loss in Acromegaly - A Review.

Authors:  Liane Sousa Teixeira; Isabelle Braz de Oliveira Silva; Andre Luiz Lopes Sampaio; Carlos Augusto Pires de Oliveira; Fayez Bahamad Júnior
Journal:  Int Arch Otorhinolaryngol       Date:  2017-06-16

5.  Sensorineural hearing loss in acromegalic patients under treatment.

Authors:  Marcelo Alexandre Carvalho; Renan Magalhães Montenegro Júnior; Marcos Rabelo de Freitas; Lúcio Vilar; Alessandra Teixeira Bezerra de Mendonça; Renan Magalhães Montenegro
Journal:  Braz J Otorhinolaryngol       Date:  2012 Jul-Aug

6.  Prevalence of comorbidities and associated factors in acromegaly patients in the Turkish population

Authors:  Mustafa Can; Muhammet Kocabaş; İlker Çordan; Hatice Çalışkan Burgucu; Melia Karaköse; Mustafa Kulaksızoğlu; Feridun Karakurt
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.